• Report Description
  • Table Of Content
  • Request Methodology

Global smart inhalers market accounted for USD 23.8 million in 2017 and is estimated to reach USD 152.9 million in 2023, registering a compound annual growth rate (CAGR) of 53.6% between 2018 and 2023.

Growth Drivers & Barriers:
Advantages and benefits of smart inhalers such as tracking usage of dose, dose alert through timer reminder, among others is anticipated to foster the growth of the market during the forecast period. Further, smart inhalers market is witnessing gamut of activities. Manufacturers are continuously engaged in new product launch and acquisition. Further, many key pharmaceutical companies are entering into smart inhalers market which is envisioned to bolster the growth of the market.

Factors such as increasing air pollution and rising prevalence of asthma and COPD is also believed to impel the growth of the market in the years ahead. Moreover, rising inclination of patients towards digital medical devices is also believed to positively impact the growth of global smart inhalers market.

On the contrary, limited availability in global markets and data privacy concerns are some of few factors which are believed to restraint the growth of the global smart inhalers market.

Regional Outlook:
In the terms of geography, the smart inhalers market is analyzed into North America, Latin America, Asia Pacific, Europe and Middle East & Africa. Among these regions, North America is slated to account for highest percentage of market share in overall smart inhalers market during the forecast period. Also, Asia Pacific smart inhalers market is expected to showcase highest growth rate in global smart inhalers market during the forecast period.

Segmentation
The research offers a comprehensive analysis of smart inhalers market with respect to following sub-markets:

By Product
- Inhalers
- Nebulizer

By Indication
- Asthma
- COPD

By Geography
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Competitive Landscape
The report profiles various major market players such as

- Teva Pharmaceutical Industries Ltd.
- Vectura Group plc.
- Boehringer Ingelheim GmbH
- AstraZeneca plc
- Cohero Health, LLC
- Propeller Health
- OPKO Health, Inc.
- Adherium Limited
- Novartis AG
- GlaxoSmithKline plc
- Others Major and Niche Players

Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, risk analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development expansion and other market activities.

The study also provides company’s positioning and market share in smart inhalers market.

Timeline Considered for Analysis:
- 2017: Base Year
- 2018: Estimated Year
- 2019 to 2023: Forecasted Year

Research Scope and Deliverables
Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis

Market Segmentation Analysis:
Industry report analyzes the global smart inhalers market by the following segments:
- Product
- Indication

Geographic Market Analysis:
The report offers separate analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, further breakdown of market data and analysis of region into countries is covered in the report.

Key Questions Answered in the Global Smart inhalers Industry Report
- What is the overall market size in 2017? What will be the market growth during the forecast period i.e. 2018-2023?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

1. Executive Summary

2. Methodology
2.1. Research Methodology
2.2. Geographic Scope
2.3. Years Considered

3. Market Overview
3.1. Overview and Definition
3.1.1. Market Definition
3.1.2. Geographic Regions Definition
3.1.3. Smart Inhalers Definition
3.2. Industry Development
3.3. Porter’s Five Force Analysis
3.4. Industry Value Chain Analysis
4. Growth Drivers & Barriers in Global Smart Inhalers Market
5. Trends in Global Smart Inhalers Market
6. Global Smart Inhalers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

7. Global Smart Inhalers Market Segmentation Analysis, By Product
7.1. Introduction
7.2. BPS Analysis by Product
7.3. Market Attractiveness by Product
7.4. Inhalers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
7.5. Nebulizer Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

8. Global Smart Inhalers Market Segmentation Analysis, By Indication
8.1. Introduction
8.2. BPS Analysis by Indication
8.3. Market Attractiveness by Indication
8.4. Asthma Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
8.5. COPD Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9. Geographical Analysis
9.1. North America Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.1. By Product
9.1.1.1. Introduction
9.1.1.2. BPS Analysis by Product
9.1.1.3. Market Attractiveness by Product
9.1.1.4. Inhalers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.1.5. Nebulizer Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.2. By Indication
9.1.2.1. Introduction
9.1.2.2. BPS Analysis by Indication
9.1.2.3. Market Attractiveness by Indication
9.1.2.4. Asthma Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.2.5. COPD Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.3. By Country
9.1.3.1. Introduction
9.1.3.2. BPS Analysis By Country
9.1.3.3. Market Attractiveness By Country
9.1.3.4. U.S. Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.1.3.5. Canada Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9.2. Europe Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.1. By Product
9.2.1.1. Introduction
9.2.1.2. BPS Analysis by Product
9.2.1.3. Market Attractiveness by Product
9.2.1.4. Inhalers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.1.5. Nebulizer Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.2. By Indication
9.2.2.1. Introduction
9.2.2.2. BPS Analysis by Indication
9.2.2.3. Market Attractiveness by Indication
9.2.2.4. Asthma Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.2.5. COPD Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3. By Country
9.2.3.1. Introduction
9.2.3.2. BPS Analysis By Country
9.2.3.3. Market Attractiveness By Country
9.2.3.4. Germany Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.5. United Kingdom Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.6. France Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.7. Italy Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.8. Spain Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.9. Russia Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.2.3.10. Rest of Europe Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9.3. Asia Pacific Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.1. By Product
9.3.1.1. Introduction
9.3.1.2. BPS Analysis by Product
9.3.1.3. Market Attractiveness by Product
9.3.1.4. Inhalers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.1.5. Nebulizer Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.2. By Indication
9.3.2.1. Introduction
9.3.2.2. BPS Analysis by Indication
9.3.2.3. Market Attractiveness by Indication
9.3.2.4. Asthma Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.2.5. COPD Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3. By Country
9.3.3.1. Introduction
9.3.3.2. BPS Analysis By Country
9.3.3.3. Market Attractiveness By Country
9.3.3.4. China Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.5. India Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.6. Japan Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.7. Indonesia Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.8. Taiwan Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.9. Australia Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.10. New Zealand Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.3.3.11. Rest of Asia Pacific Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9.4. Latin America Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.1. By Product
9.4.1.1. Introduction
9.4.1.2. BPS Analysis by Product
9.4.1.3. Market Attractiveness by Product
9.4.1.4. Inhalers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.1.5. Nebulizer Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.2. By Indication
9.4.2.1. Introduction
9.4.2.2. BPS Analysis by Indication
9.4.2.3. Market Attractiveness by Indication
9.4.2.4. Asthma Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.2.5. COPD Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.3. By Country
9.4.3.1. Introduction
9.4.3.2. BPS Analysis by Country
9.4.3.3. Market Attractiveness by Country
9.4.3.4. Brazil Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.3.5. Mexico Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.4.3.6. Rest of Latin America Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

9.5. Middle East & Africa Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.1. By Product
9.5.1.1. Introduction
9.5.1.2. BPS Analysis by Product
9.5.1.3. Market Attractiveness by Product
9.5.1.4. Inhalers Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.1.5. Nebulizer Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.2. By Indication
9.5.2.1. Introduction
9.5.2.2. BPS Analysis by Indication
9.5.2.3. Market Attractiveness by Indication
9.5.2.4. Asthma Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.2.5. COPD Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.3. By Country
9.5.3.1. Introduction
9.5.3.2. BPS Analysis By Country
9.5.3.3. Market Attractiveness By Country
9.5.3.4. GCC Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.3.5. North Africa Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.3.6. South Africa Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023
9.5.3.7. Rest of Middle East & Africa Market Value (USD Million), Forecast & Y-o-Y Growth Analysis, 2017-2023

10. Company Profile
10.1. Company Analysis
10.1.1. Teva Pharmaceutical Industries Ltd.
10.1.1.1. Company Overview
10.1.1.2. Product Offered
10.1.1.3. Business Strategy
10.1.1.4. Financials
10.1.1.5. SWOT Analysis
10.1.1.6. Market Share Analysis
10.1.1.7. Key Achievements & Developments
10.1.2. Vectura Group plc.
10.1.3. Boehringer Ingelheim GmbH
10.1.4. AstraZeneca plc
10.1.5. Cohero Health, LLC
10.1.6. Propeller Health
10.1.7. OPKO Health, Inc.
10.1.8. Adherium Limited
10.1.9. Novartis AG
10.1.10. GlaxoSmithKline plc
10.1.11. Others Major and Niche Players

Select License Type
  • Single User License $4185 USD
  • Multi-User License $5175 USD
  • Corporate User License $5895 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients